Isolation of human antigen‐specific regulatory T cells with high suppressive function
Open Access
- 2 July 2014
- journal article
- clinical trial
- Published by Wiley in European Journal of Immunology
- Vol. 44 (9) , 2592-2602
Abstract
Adoptive transfer of regulatory T (Treg) cells could be an alternative to chronic immunosuppression for prevention of allogeneic graft rejection. While polyspecific Treg cells can prevent immune responses under lymphopenic conditions, Ag‐specific Treg cells are needed to treat autoimmunity and graft rejection. Yet, reliable markers for Ag‐specific Treg cells are missing. We report that latency‐associated peptide (LAP) and glycoprotein A repetitions predominant (GARP) can identify human Ag‐specific Treg cells. In addition, we show that the depletion of CD154+ cells from LAP+ or GARP+ Treg cells increases the Treg‐cell purity to over 90%, as assessed by epigenetic analysis. These Ag‐specific Treg cells can be isolated magnetically and might contribute to the development of GMP‐based protocols. In addition, Ag‐specific Treg cells are functionally far superior to CD4+CD25high or CD4+CD25highCD127low Treg cells in vitro and in preventing strong alloreactions in humanized mice. They could, therefore, have a high therapeutic potential for the control of alloimmune, autoimmune, and allergic immune responses in patients.Keywords
Funding Information
- German research organization (DFG) (SFB738-B4)
- Integrated Research and Training Center Transplantation (IFB-Tx) reference number: 01EO0802 (CBT-3)
This publication has 41 references indexed in Scilit:
- Clinical perspectives for regulatory T cells in transplantation toleranceSeminars in Immunology, 2011
- Ex Vivo–Expanded Human Regulatory T Cells Prevent the Rejection of Skin Allografts in a Humanized Mouse ModelTransplantation, 2010
- Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes SocietyClinical and Experimental Immunology, 2010
- GARP (LRRC32) is essential for the surface expression of latent TGF-β on platelets and activated FOXP3 + regulatory T cellsProceedings of the National Academy of Sciences, 2009
- Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion culturesBlood, 2009
- Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytesNature Medicine, 2007
- Induction of FOXP3 expression in naive human CD4+FOXP3− T cells by T-cell receptor stimulation is transforming growth factor-β–dependent but does not confer a regulatory phenotypeBlood, 2007
- CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cellsJournal of Experimental Medicine, 2006
- Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cellsJournal of Experimental Medicine, 2006
- Direct access to CD4+ T cells specific for defined antigens according to CD154 expressionNature Medicine, 2005